Literature DB >> 22089317

Is cognitive functioning impaired in methamphetamine users? A critical review.

Carl L Hart1, Caroline B Marvin, Rae Silver, Edward E Smith.   

Abstract

The prevailing view is that recreational methamphetamine use causes a broad range of severe cognitive deficits, despite the fact that concerns have been raised about interpretations drawn from the published literature. This article addresses an important gap in our knowledge by providing a critical review of findings from recent research investigating the impact of recreational methamphetamine use on human cognition. Included in the discussion are findings from studies that have assessed the acute and long-term effects of methamphetamine on several domains of cognition, including visuospatial perception, attention, inhibition, working memory, long-term memory, and learning. In addition, relevant neuroimaging data are reviewed in an effort to better understand neural mechanisms underlying methamphetamine-related effects on cognitive functioning. In general, the data on acute effects show that methamphetamine improves cognitive performance in selected domains, that is, visuospatial perception, attention, and inhibition. Regarding long-term effects on cognitive performance and brain-imaging measures, statistically significant differences between methamphetamine users and control participants have been observed on a minority of measures. More importantly, however, the clinical significance of these findings may be limited because cognitive functioning overwhelmingly falls within the normal range when compared against normative data. In spite of these observations, there seems to be a propensity to interpret any cognitive and/or brain difference(s) as a clinically significant abnormality. The implications of this situation are multiple, with consequences for scientific research, substance-abuse treatment, and public policy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22089317      PMCID: PMC3260986          DOI: 10.1038/npp.2011.276

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  82 in total

Review 1.  New insights into the mechanism of action of amphetamines.

Authors:  Annette E Fleckenstein; Trent J Volz; Evan L Riddle; James W Gibb; Glen R Hanson
Journal:  Annu Rev Pharmacol Toxicol       Date:  2007       Impact factor: 13.820

Review 2.  Basal ganglia and dopamine contributions to probabilistic category learning.

Authors:  D Shohamy; C E Myers; J Kalanithi; M A Gluck
Journal:  Neurosci Biobehav Rev       Date:  2007-08-10       Impact factor: 8.989

3.  Frontal glucose hypometabolism in abstinent methamphetamine users.

Authors:  Seog Ju Kim; In Kyoon Lyoo; Jaeuk Hwang; Young Hoon Sung; Ho Young Lee; Dong Soo Lee; Do-Un Jeong; Perry F Renshaw
Journal:  Neuropsychopharmacology       Date:  2005-07       Impact factor: 7.853

4.  Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence.

Authors:  N D Volkow; L Chang; G J Wang; J S Fowler; D Franceschi; M Sedler; S J Gatley; E Miller; R Hitzemann; Y S Ding; J Logan
Journal:  J Neurosci       Date:  2001-12-01       Impact factor: 6.167

5.  Neuropsychological function and delay discounting in methamphetamine-dependent individuals.

Authors:  William F Hoffman; Meredith Moore; Raymond Templin; Bentson McFarland; Robert J Hitzemann; Suzanne H Mitchell
Journal:  Psychopharmacology (Berl)       Date:  2006-08-17       Impact factor: 4.530

6.  Decreased frontal white-matter integrity in abstinent methamphetamine abusers.

Authors:  Ain Chung; In Kyoon Lyoo; Seog Ju Kim; Jaeuk Hwang; Soojeong C Bae; Young Hoon Sung; Minyoung E Sim; In Chan Song; Jihyun Kim; Kee Hyun Chang; Perry F Renshaw
Journal:  Int J Neuropsychopharmacol       Date:  2006-12-06       Impact factor: 5.176

7.  Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers.

Authors:  N D Volkow; L Chang; G J Wang; J S Fowler; D Franceschi; M J Sedler; S J Gatley; R Hitzemann; Y S Ding; C Wong; J Logan
Journal:  Am J Psychiatry       Date:  2001-03       Impact factor: 18.112

8.  The relationship between methamphetamine use and increased dental disease.

Authors:  Vivek Shetty; Larissa J Mooney; Corwin M Zigler; Thomas R Belin; Debra Murphy; Richard Rawson
Journal:  J Am Dent Assoc       Date:  2010-03       Impact factor: 3.634

9.  Prefrontal grey-matter changes in short-term and long-term abstinent methamphetamine abusers.

Authors:  Seog Ju Kim; In Kyoon Lyoo; Jaeuk Hwang; Ain Chung; Young Hoon Sung; Jihyun Kim; Do-Hoon Kwon; Kee Hyun Chang; Perry F Renshaw
Journal:  Int J Neuropsychopharmacol       Date:  2005-06-28       Impact factor: 5.176

10.  Effects of intranasal methamphetamine on metacognition of agency.

Authors:  Matthew G Kirkpatrick; Janet Metcalfe; Matthew J Greene; Carl L Hart
Journal:  Psychopharmacology (Berl)       Date:  2007-11-28       Impact factor: 4.530

View more
  67 in total

1.  What matters in measuring methamphetamine-related cognitive impairments: 'abnormality detection' versus 'everyday import'?

Authors:  Doris E Payer; Andy C Dean; Isabelle Boileau
Journal:  Neuropsychopharmacology       Date:  2012-04       Impact factor: 7.853

Review 2.  Cognitive enhancement as a treatment for drug addictions.

Authors:  Mehmet Sofuoglu; Elise E DeVito; Andrew J Waters; Kathleen M Carroll
Journal:  Neuropharmacology       Date:  2012-06-23       Impact factor: 5.250

3.  Frontal systems deficits in stimulant-dependent patients: evidence of pre-illness dysfunction and relationship to treatment response.

Authors:  Theresa M Winhusen; Eugene C Somoza; Daniel F Lewis; Frankie B Kropp; Viviana Elizabeth Horigian; Bryon Adinoff
Journal:  Drug Alcohol Depend       Date:  2012-07-06       Impact factor: 4.492

4.  Prior methamphetamine self-administration attenuates serotonergic deficits induced by subsequent high-dose methamphetamine administrations.

Authors:  Lisa M McFadden; Madison M Hunt; Paula L Vieira-Brock; Janice Muehle; Shannon M Nielsen; Scott C Allen; Glen R Hanson; Annette E Fleckenstein
Journal:  Drug Alcohol Depend       Date:  2012-05-28       Impact factor: 4.492

Review 5.  Methamphetamine addiction: involvement of CREB and neuroinflammatory signaling pathways.

Authors:  Irina N Krasnova; Zuzana Justinova; Jean Lud Cadet
Journal:  Psychopharmacology (Berl)       Date:  2016-02-12       Impact factor: 4.530

6.  Marijuana and pregnancy: objective education is good, but biased education is not.

Authors:  Ciara A Torres; Carl L Hart
Journal:  Am J Obstet Gynecol       Date:  2017-04-08       Impact factor: 8.661

7.  Dysregulation of D₂-mediated dopamine transmission in monkeys after chronic escalating methamphetamine exposure.

Authors:  Stephanie M Groman; Buyean Lee; Emanuele Seu; Alex S James; Karen Feiler; Mark A Mandelkern; Edythe D London; J David Jentsch
Journal:  J Neurosci       Date:  2012-04-25       Impact factor: 6.167

8.  Effects of amphetamine exposure during adolescence on behavior and prelimbic cortex neuron activity in adulthood.

Authors:  Luke K Sherrill; Joshua M Gulley
Journal:  Brain Res       Date:  2018-05-21       Impact factor: 3.252

9.  Conditional Effects of Lifetime Alcohol Consumption on Methamphetamine-Associated Neurocognitive Performance.

Authors:  Rowan Saloner; Emily W Paolillo; Anya Umlauf; David J Moore; Robert K Heaton; Igor Grant; Mariana Cherner
Journal:  J Int Neuropsychol Soc       Date:  2019-06-10       Impact factor: 2.892

10.  Effects of self-administered methamphetamine on discrimination learning and reversal in nonhuman primates.

Authors:  Brian D Kangas; Jack Bergman
Journal:  Psychopharmacology (Berl)       Date:  2016-02       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.